Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Enterprise Value: 2019-2025

Historic Enterprise Value for IDEAYA Biosciences (IDYA) over the last 7 years, with Sep 2025 value amounting to $1.6 billion.

  • IDEAYA Biosciences' Enterprise Value fell 9.02% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$440.7 million, marking a year-over-year decrease of 160.45%. This contributed to the annual value of $1.5 billion for FY2024, which is 12.63% down from last year.
  • According to the latest figures from Q3 2025, IDEAYA Biosciences' Enterprise Value is $1.6 billion, which was up 36.43% from $1.2 billion recorded in Q2 2025.
  • IDEAYA Biosciences' Enterprise Value's 5-year high stood at $2.6 billion during Q1 2024, with a 5-year trough of $179.6 million in Q1 2022.
  • Its 3-year average for Enterprise Value is $1.4 billion, with a median of $1.5 billion in 2024.
  • Its Enterprise Value has fluctuated over the past 5 years, first surged by 11,371.27% in 2021, then plummeted by 71.97% in 2022.
  • Over the past 5 years, IDEAYA Biosciences' Enterprise Value (Quarterly) stood at $663.3 million in 2021, then declined by 23.20% to $509.4 million in 2022, then spiked by 247.15% to $1.8 billion in 2023, then decreased by 12.63% to $1.5 billion in 2024, then declined by 9.02% to $1.6 billion in 2025.
  • Its Enterprise Value stands at $1.6 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $741.4 million for Q1 2025.